Pharmacokinetics of Newer Drugs in Patients with Renal Impairment (Part II)
- 1 May 1991
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 20 (5) , 389-410
- https://doi.org/10.2165/00003088-199120050-00004
Abstract
Cardiovascular diseases occur frequently in patients with renal failure. Any pharmacokinetic impairment in these diseases should be considered when individualising drug therapy. The pharmacokinetics...Keywords
This publication has 99 references indexed in Scilit:
- Clinical Pharmacokinetics of the Newer ACE InhibitorsClinical Pharmacokinetics, 1990
- The Influence of Renal Function on Clinical Pharmacokinetics of MoxonidineClinical Pharmacokinetics, 1988
- Multiple-Dose Pharmacokinetics of Nilvadipine in Healthy VolunteersThe Journal of Clinical Pharmacology, 1988
- Clinical Pharmacokinetics of EncainideClinical Pharmacokinetics, 1988
- Clinical Pharmacokinetics of UrapidilClinical Pharmacokinetics, 1988
- Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal functionEuropean Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of Moxonidine After Single and Repeated Daily Doses in Healthy VolunteersThe Journal of Clinical Pharmacology, 1987
- Pharmacokinetics of Cibenzoline in Patients With Renal ImpairmentThe Journal of Clinical Pharmacology, 1985
- Clinical Pharmacokinetics of the Newer Antiarrhythmic AgentsClinical Pharmacokinetics, 1984
- Pharmacokinetics of Lorcainide in ManClinical Pharmacokinetics, 1978